Eiken Chemical

Eiken Chemical, established in 1939, is a prominent Japanese company specializing in the manufacturing and sales of clinical diagnostics and related equipment. Headquartered in Tokyo, the company operates within the Medical Devices & Equipment and Manufacturing sectors. With a history spanning over eight decades, Eiken Chemical has built a reputation for developing and distributing essential tools for medical laboratories and healthcare providers. Its business model is primarily B2B, serving professional clients in the healthcare industry.

The company's extensive product portfolio includes a wide array of reagents such as fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, and clinical chemistry reagents. Eiken Chemical is also a key provider of molecular genetics solutions and medical devices. A significant technological achievement was the development of the Loop-mediated isothermal amplification (LAMP) method in 1998, a highly valuable nucleic acid amplification technique widely adopted across life science fields. The company employs between 500-1,000 individuals, contributing to its operational capacity. Meet Eiken Chemical's team to understand the expertise driving these innovations.

Eiken Chemical is publicly traded under the ticker TYO: 4549. The company generates substantial revenue, reported at $273.4M, reflecting its significant market presence. Its operations are primarily focused on the Asia-Pacific region, with a strong base in Japan. The company's commitment to advancing diagnostic technology and providing reliable medical equipment solidifies its position in the global healthcare market.